Association of -94 ATTG insertion/deletion NFkB1 and c.126G>A NFkBIA genetic polymorphisms with oxidative and nitrosative stress biomarkers in Brazilian subjects with Parkinson’s Disease

•Oxidative/nitrosative stress is influenced by NFκB1 and NFκBIA polymorphisms.•NFκB1 and NFκBIA polymorphisms are not directly associated with PD.•Plasma LOOH is a good biomarker for PD.•Prospect of new genetic elements may be a potential target to unravel PD etiology. Parkinson's disease (PD)...

Full description

Saved in:
Bibliographic Details
Published inNeuroscience letters Vol. 740; p. 135487
Main Authors Baltus, Thiago Hissnauer Leal, Morelli, Nayara Rampazzo, de Farias, Carine Coneglian, Trugilo, Kleber Paiva, Okuyama, Nádia Calvo Martins, de Oliveira, Karen Brajão, de Melo, Lucio Baena, Smaili, Suhaila Mahmoud, Barbosa, Décio Sabbatini
Format Journal Article
LanguageEnglish
Published Ireland Elsevier B.V 01.01.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:•Oxidative/nitrosative stress is influenced by NFκB1 and NFκBIA polymorphisms.•NFκB1 and NFκBIA polymorphisms are not directly associated with PD.•Plasma LOOH is a good biomarker for PD.•Prospect of new genetic elements may be a potential target to unravel PD etiology. Parkinson's disease (PD) is a complex neurodegenerative disorder, resulting dopaminergic neuronal cell death in the substantia nigra. The disease is characterized by major motor impairment, being bradykinesia, rest tremor, rigidity and loss of postural reflexes the most common, while autonomic dysfunctions, sleep disturbances and psychiatric disorders are some of the wide range of non-motor symptoms. Several processes have been identified to be associated with disease development, such as mitochondrial dysfunction, oxidative/nitrosative stress and neuroinflammation. NF-κB is an important transcription factor that regulates several inflammatory elements and pathways, and polymorphisms on NFKB1 and NFKBIA genes can potentially influence redox balance towards a pro-oxidative frame, modulating disease progression. Evaluation of these polymorphisms in the redox status of PD subjects could provide new insights on the pathogenesis of this disorder. The study aimed to test associations of -94 in./del ATTG NFKB1 (rs28362491) and c.*126G > A NFKBIA (rs696) polymorphisms with PD development, and to test the influence of both polymorphisms on oxidative/nitrosative stress (OS/NS) parameters. A total of 110 Brazilian individuals were enrolled, being 55 subjects recruited from University Hospital of Londrina as the PD group, and 55 subjects matched for age, sex and ethnicity composed the healthy control (HC) group. NFkB1 and NFkBIA polymorphisms were genotyped by PCR-RFLP. Lipid hydroperoxides (LOOH), nitric oxide metabolites (NOx), advanced oxidation protein products (AOPP), sulfhydryl groups (SH), total radical trapping antioxidant parameter (TRAP) and paraoxonase-1 activity (PON-1) were assessed. Despite no association of polymorphisms on disease development was observed, in PD subjects the NFKB1 del/del genotype was associated with higher levels of LOOH, while NFkBIA GA and AA genotypes were associated with higher NOx levels, suggesting that NFkB plays a role in PD susceptbility. In conclusion, the prospect of genetic polymorphisms of elements involved in inflammation and OS/NS might be a new approach to unravel PD etiology.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0304-3940
1872-7972
1872-7972
DOI:10.1016/j.neulet.2020.135487